NanoMedex Pharmaceuticals
Middleton, Wisconsin, United States
About NanoMedex Pharmaceuticals
Nanotechnology of Microemulsions. NanoMedex Pharmaceuticals, Inc. has developed a formulation strategy to allow drugs that are only soluble in oil to be soluble in water. To administer a drug intravenously the drug must first be dissolved in water. The NanoMedex nanotechnology formulation strategy utilizes components that encapsulate the active pharmaceutical ingredient (API) into spheres (5-30 nm) so small they allow the drug to become randomly dispersed in water and act as if the drug has dissolved in the water.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $500.0K
- Last round: Series Unknown (Jun 2009)
- Website: nanomedex.com
- Phone: 608-310-4454
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/nanomedex-pharmaceuticals-2562144 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.